Annual EBIT
-$66.42 M
-$29.50 M-79.91%
31 December 2023
Summary:
Armata Pharmaceuticals annual earnings before interest & taxes is currently -$66.42 million, with the most recent change of -$29.50 million (-79.91%) on 31 December 2023. During the last 3 years, it has fallen by -$44.87 million (-208.17%). ARMP annual EBIT is now -1593.93% below its all-time high of -$3.86 million.ARMP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$2.56 M
-$14.26 M-121.86%
30 September 2024
Summary:
Armata Pharmaceuticals quarterly earnings before interest & taxes is currently -$2.56 million, with the most recent change of -$14.26 million (-121.86%) on 30 September 2024. Over the past year, it has increased by +$27.43 million (+91.47%). ARMP quarterly EBIT is now -121.52% below its all-time high of $11.88 million, reached on 30 September 2001.ARMP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$32.45 M
+$27.43 M+45.80%
30 September 2024
Summary:
Armata Pharmaceuticals TTM earnings before interest & taxes is currently -$32.45 million, with the most recent change of +$27.43 million (+45.80%) on 30 September 2024. Over the past year, it has increased by +$25.88 million (+44.37%). ARMP TTM EBIT is now -10917.33% below its all-time high of $300.00 thousand, reached on 30 September 1993.ARMP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARMP EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -79.9% | +91.5% | +44.4% |
| 3 y3 years | -208.2% | +52.8% | -38.1% |
| 5 y5 years | -527.0% | +62.2% | -229.9% |
ARMP EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -208.2% | at low | -121.9% | +91.5% | -40.5% | +56.8% |
| 5 y | 5 years | -527.0% | at low | -121.9% | +91.5% | -229.9% | +56.8% |
| alltime | all time | -1593.9% | at low | -121.5% | +94.8% | <-9999.0% | +56.8% |
Armata Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.56 M(-121.9%) | -$32.45 M(-45.8%) |
| June 2024 | - | $11.70 M(-150.4%) | -$59.88 M(-20.3%) |
| Mar 2024 | - | -$23.20 M(+26.1%) | -$75.13 M(+13.1%) |
| Dec 2023 | -$66.42 M(+79.9%) | -$18.40 M(-38.6%) | -$66.42 M(+13.9%) |
| Sept 2023 | - | -$29.98 M(+745.4%) | -$58.34 M(+57.8%) |
| June 2023 | - | -$3.55 M(-75.5%) | -$36.97 M(-13.3%) |
| Mar 2023 | - | -$14.49 M(+40.5%) | -$42.64 M(+15.5%) |
| Dec 2022 | -$36.92 M(+59.9%) | -$10.31 M(+19.7%) | -$36.92 M(+13.1%) |
| Sept 2022 | - | -$8.61 M(-6.6%) | -$32.66 M(+10.9%) |
| June 2022 | - | -$9.22 M(+5.1%) | -$29.46 M(+11.4%) |
| Mar 2022 | - | -$8.78 M(+45.1%) | -$26.43 M(+14.5%) |
| Dec 2021 | -$23.09 M(+7.1%) | -$6.05 M(+11.6%) | -$23.09 M(-1.7%) |
| Sept 2021 | - | -$5.42 M(-12.5%) | -$23.49 M(-0.9%) |
| June 2021 | - | -$6.19 M(+14.0%) | -$23.69 M(+7.4%) |
| Mar 2021 | - | -$5.43 M(-15.7%) | -$22.07 M(+2.4%) |
| Dec 2020 | -$21.55 M(+16.2%) | -$6.45 M(+14.7%) | -$21.55 M(+10.6%) |
| Sept 2020 | - | -$5.62 M(+23.0%) | -$19.49 M(-5.6%) |
| June 2020 | - | -$4.57 M(-7.1%) | -$20.63 M(+3.0%) |
| Mar 2020 | - | -$4.92 M(+12.3%) | -$20.03 M(+8.0%) |
| Dec 2019 | -$18.55 M(+75.1%) | -$4.38 M(-35.2%) | -$18.55 M(+88.6%) |
| Sept 2019 | - | -$6.76 M(+70.4%) | -$9.84 M(+77.7%) |
| June 2019 | - | -$3.97 M(+15.6%) | -$5.54 M(+19.9%) |
| Mar 2019 | - | -$3.43 M(-179.3%) | -$4.62 M(+8.9%) |
| Dec 2018 | -$10.59 M(+2.3%) | $4.33 M(-275.8%) | -$4.24 M(-61.2%) |
| Sept 2018 | - | -$2.46 M(-19.3%) | -$10.94 M(+18.6%) |
| June 2018 | - | -$3.05 M(-0.1%) | -$9.22 M(-8.3%) |
| Mar 2018 | - | -$3.06 M(+29.2%) | -$10.05 M(-2.9%) |
| Dec 2017 | -$10.36 M(-25.1%) | -$2.37 M(+217.0%) | -$10.36 M(+0.5%) |
| Sept 2017 | - | -$746.00 K(-80.8%) | -$10.31 M(-20.5%) |
| June 2017 | - | -$3.89 M(+15.7%) | -$12.97 M(+2.3%) |
| Mar 2017 | - | -$3.36 M(+45.0%) | -$12.67 M(-8.4%) |
| Dec 2016 | -$13.83 M(+35.2%) | -$2.32 M(-32.0%) | -$13.83 M(-4.3%) |
| Sept 2016 | - | -$3.41 M(-5.1%) | -$14.45 M(+7.3%) |
| June 2016 | - | -$3.59 M(-20.6%) | -$13.47 M(+8.0%) |
| Mar 2016 | - | -$4.52 M(+53.7%) | -$12.48 M(+22.0%) |
| Dec 2015 | -$10.23 M(-16.5%) | -$2.94 M(+21.1%) | -$10.23 M(+3.7%) |
| Sept 2015 | - | -$2.43 M(-6.3%) | -$9.86 M(-8.9%) |
| June 2015 | - | -$2.59 M(+14.3%) | -$10.82 M(-9.7%) |
| Mar 2015 | - | -$2.27 M(-11.9%) | -$11.98 M(-2.2%) |
| Dec 2014 | -$12.25 M(-80.2%) | -$2.57 M(-24.1%) | -$12.25 M(+32.5%) |
| Sept 2014 | - | -$3.39 M(-9.5%) | -$9.24 M(-83.1%) |
| June 2014 | - | -$3.75 M(+47.9%) | -$54.57 M(-13.4%) |
| Mar 2014 | - | -$2.53 M(-683.9%) | -$63.00 M(+2.1%) |
| Dec 2013 | -$61.71 M(+1473.9%) | $434.00 K(-100.9%) | -$61.71 M(-0.7%) |
| Sept 2013 | - | -$48.72 M(+300.0%) | -$62.15 M(+362.9%) |
| June 2013 | - | -$12.18 M(+877.6%) | -$13.43 M(+977.6%) |
| Mar 2013 | - | -$1.25 M(-247.6%) | -$1.25 M(-54.0%) |
| Dec 2012 | -$3.92 M(-68.1%) | - | - |
| Sept 2009 | - | $844.00 K(+94.0%) | -$2.71 M(-57.0%) |
| June 2009 | - | $435.00 K(-129.8%) | -$6.30 M(-39.4%) |
| Mar 2009 | - | -$1.46 M(-42.3%) | -$10.41 M(-15.3%) |
| Dec 2008 | -$12.29 M(-14.7%) | -$2.53 M(-8.1%) | -$12.29 M(-9.8%) |
| Sept 2008 | - | -$2.75 M(-25.1%) | -$13.62 M(-2.7%) |
| June 2008 | - | -$3.67 M(+10.0%) | -$13.99 M(-1.2%) |
| Mar 2008 | - | -$3.34 M(-13.5%) | -$14.15 M(-68.1%) |
| Dec 2007 | -$14.41 M | -$3.86 M(+23.4%) | -$44.41 M(+5.3%) |
| Sept 2007 | - | -$3.13 M(-18.6%) | -$42.19 M(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | -$3.84 M(-88.6%) | -$41.86 M(-36.2%) |
| Mar 2007 | - | -$33.59 M(+1951.7%) | -$65.58 M(+88.9%) |
| Dec 2006 | -$34.72 M(+96.9%) | -$1.64 M(-41.5%) | -$34.72 M(-5.2%) |
| Sept 2006 | - | -$2.80 M(-89.8%) | -$36.62 M(-4.9%) |
| June 2006 | - | -$27.56 M(+910.3%) | -$38.50 M(+141.5%) |
| Mar 2006 | - | -$2.73 M(-22.8%) | -$15.94 M(-9.6%) |
| Dec 2005 | -$17.64 M(+23.5%) | -$3.53 M(-24.4%) | -$17.64 M(+8.6%) |
| Sept 2005 | - | -$4.67 M(-6.6%) | -$16.23 M(+8.8%) |
| June 2005 | - | -$5.01 M(+13.2%) | -$14.92 M(+6.2%) |
| Mar 2005 | - | -$4.42 M(+107.7%) | -$14.04 M(-1.7%) |
| Dec 2004 | -$14.29 M(+65.8%) | -$2.13 M(-36.5%) | -$14.29 M(-14.7%) |
| Sept 2004 | - | -$3.36 M(-18.8%) | -$16.74 M(+24.3%) |
| June 2004 | - | -$4.13 M(-11.4%) | -$13.46 M(+3.2%) |
| Mar 2004 | - | -$4.67 M(+1.8%) | -$13.04 M(+51.4%) |
| Dec 2003 | -$8.61 M(-53.4%) | -$4.58 M(+5778.2%) | -$8.61 M(+56.4%) |
| Sept 2003 | - | -$78.00 K(-97.9%) | -$5.51 M(-44.6%) |
| June 2003 | - | -$3.71 M(+1453.1%) | -$9.94 M(-20.5%) |
| Mar 2003 | - | -$239.00 K(-83.9%) | -$12.50 M(-32.4%) |
| Dec 2002 | -$18.49 M(-35.4%) | -$1.48 M(-67.2%) | -$18.49 M(-33.7%) |
| Sept 2002 | - | -$4.51 M(-28.1%) | -$27.88 M(+142.8%) |
| June 2002 | - | -$6.27 M(+0.7%) | -$11.48 M(+9.7%) |
| Mar 2002 | - | -$6.23 M(-42.7%) | -$10.47 M(+0.9%) |
| Dec 2001 | -$28.60 M(-37.6%) | -$10.87 M(-191.4%) | -$10.37 M(-73.6%) |
| Sept 2001 | - | $11.88 M(-326.0%) | -$39.35 M(-22.3%) |
| June 2001 | - | -$5.26 M(-14.3%) | -$50.67 M(+2.8%) |
| Mar 2001 | - | -$6.13 M(-84.6%) | -$49.29 M(+7.6%) |
| Dec 2000 | -$45.80 M(+312.7%) | -$39.85 M(-7121.3%) | -$45.80 M(+448.0%) |
| Sept 2000 | - | $567.50 K(-114.6%) | -$8.36 M(-31.1%) |
| June 2000 | - | -$3.88 M(+46.3%) | -$12.13 M(+9.7%) |
| Mar 2000 | - | -$2.65 M(+10.4%) | -$11.05 M(-1.3%) |
| Dec 1999 | -$11.10 M(+22.0%) | -$2.40 M(-25.0%) | -$11.20 M(+49.3%) |
| Sept 1999 | - | -$3.20 M(+14.3%) | -$7.50 M(-3.8%) |
| June 1999 | - | -$2.80 M(0.0%) | -$7.80 M(-3.7%) |
| Mar 1999 | - | -$2.80 M(-315.4%) | -$8.10 M(-10.0%) |
| Dec 1998 | -$9.10 M(-38.9%) | $1.30 M(-137.1%) | -$9.00 M(-37.5%) |
| Sept 1998 | - | -$3.50 M(+12.9%) | -$14.40 M(+3.6%) |
| June 1998 | - | -$3.10 M(-16.2%) | -$13.90 M(-3.5%) |
| Mar 1998 | - | -$3.70 M(-9.8%) | -$14.40 M(+1.4%) |
| Dec 1997 | -$14.90 M(+23.1%) | -$4.10 M(+36.7%) | -$14.20 M(+12.7%) |
| Sept 1997 | - | -$3.00 M(-16.7%) | -$12.60 M(-4.5%) |
| June 1997 | - | -$3.60 M(+2.9%) | -$13.20 M(+5.6%) |
| Mar 1997 | - | -$3.50 M(+40.0%) | -$12.50 M(+5.9%) |
| Dec 1996 | -$12.10 M(+16.3%) | -$2.50 M(-30.6%) | -$11.80 M(-3.3%) |
| Sept 1996 | - | -$3.60 M(+24.1%) | -$12.20 M(+13.0%) |
| June 1996 | - | -$2.90 M(+3.6%) | -$10.80 M(+4.9%) |
| Mar 1996 | - | -$2.80 M(-3.4%) | -$10.30 M(+2.0%) |
| Dec 1995 | -$10.40 M(+25.3%) | -$2.90 M(+31.8%) | -$10.10 M(+7.4%) |
| Sept 1995 | - | -$2.20 M(-8.3%) | -$9.40 M(0.0%) |
| June 1995 | - | -$2.40 M(-7.7%) | -$9.40 M(+3.3%) |
| Mar 1995 | - | -$2.60 M(+18.2%) | -$9.10 M(+42.2%) |
| Dec 1994 | -$8.30 M(+53.7%) | -$2.20 M(0.0%) | -$6.40 M(-34.0%) |
| Sept 1994 | - | -$2.20 M(+4.8%) | -$9.70 M(+31.1%) |
| June 1994 | - | -$2.10 M(-2200.0%) | -$7.40 M(+42.3%) |
| Mar 1994 | - | $100.00 K(-101.8%) | -$5.20 M(0.0%) |
| Dec 1993 | -$5.40 M | -$5.50 M(-5600.0%) | -$5.20 M(-1833.3%) |
| Sept 1993 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| June 1993 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1993 | - | $100.00 K | $100.00 K |
FAQ
- What is Armata Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals annual EBIT year-on-year change?
- What is Armata Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals quarterly EBIT year-on-year change?
- What is Armata Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals TTM EBIT year-on-year change?
What is Armata Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ARMP is -$66.42 M
What is the all time high annual EBIT for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high annual earnings before interest & taxes is -$3.86 M
What is Armata Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ARMP annual earnings before interest & taxes has changed by -$29.50 M (-79.91%)
What is Armata Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ARMP is -$2.56 M
What is the all time high quarterly EBIT for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high quarterly earnings before interest & taxes is $11.88 M
What is Armata Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ARMP quarterly earnings before interest & taxes has changed by +$27.43 M (+91.47%)
What is Armata Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ARMP is -$32.45 M
What is the all time high TTM EBIT for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high TTM earnings before interest & taxes is $300.00 K
What is Armata Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ARMP TTM earnings before interest & taxes has changed by +$25.88 M (+44.37%)